182 related articles for article (PubMed ID: 30578463)
1. Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts.
Métayer LE; Brown RD; Carlebur S; Burke GAA; Brown GC
Apoptosis; 2019 Feb; 24(1-2):145-156. PubMed ID: 30578463
[TBL] [Abstract][Full Text] [Related]
2. Use of L-asparaginase in childhood ALL.
Müller HJ; Boos J
Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
[TBL] [Abstract][Full Text] [Related]
3. The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells.
Mazloum-Ravasan S; Madadi E; Fathi Z; Mohammadi A; Mosafer J; Mansoori B; Mokhtarzadeh A; Baradaran B; Darvishi F
Int J Biol Macromol; 2020 Mar; 146():193-201. PubMed ID: 31870867
[TBL] [Abstract][Full Text] [Related]
4. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
Ronghe M; Burke GA; Lowis SP; Estlin EJ
Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.
Avramis VI; Panosyan EH
Clin Pharmacokinet; 2005; 44(4):367-93. PubMed ID: 15828851
[TBL] [Abstract][Full Text] [Related]
6. Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.
Mehta RK; Verma S; Pati R; Sengupta M; Khatua B; Jena RK; Sethy S; Kar SK; Mandal C; Roehm KH; Sonawane A
J Biol Chem; 2014 Feb; 289(6):3555-70. PubMed ID: 24297177
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
[TBL] [Abstract][Full Text] [Related]
8. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
[TBL] [Abstract][Full Text] [Related]
10. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in L-asparaginase discovery and its potential as anticancer agent.
Shrivastava A; Khan AA; Khurshid M; Kalam MA; Jain SK; Singhal PK
Crit Rev Oncol Hematol; 2016 Apr; 100():1-10. PubMed ID: 25630663
[TBL] [Abstract][Full Text] [Related]
12. Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
Wells JW; Evans CH; Scott MC; Rütgen BC; O'Brien TD; Modiano JF; Cvetkovic G; Tepic S
PLoS One; 2013; 8(1):e54464. PubMed ID: 23365669
[TBL] [Abstract][Full Text] [Related]
13. Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemia.
Cory JG; Cory AH
In Vivo; 2006; 20(5):587-9. PubMed ID: 17091764
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase.
Hlozkova K; Pecinova A; Alquezar-Artieda N; Pajuelo-Reguera D; Simcikova M; Hovorkova L; Rejlova K; Zaliova M; Mracek T; Kolenova A; Stary J; Trka J; Starkova J
BMC Cancer; 2020 Jun; 20(1):526. PubMed ID: 32503472
[TBL] [Abstract][Full Text] [Related]
16. A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL).
Johnson S; Dhamne C; Sankaran H; Gandhi KA; Rane P; Moulik NR; Jadhav SM; Gurjar M; Narula G; Banavali S; Gota V
Cancer Chemother Pharmacol; 2022 Dec; 90(6):445-453. PubMed ID: 36251032
[TBL] [Abstract][Full Text] [Related]
17. L-asparaginase: a promising chemotherapeutic agent.
Verma N; Kumar K; Kaur G; Anand S
Crit Rev Biotechnol; 2007; 27(1):45-62. PubMed ID: 17364689
[TBL] [Abstract][Full Text] [Related]
18. The clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia.
Estlin EJ; Ronghe M; Burke GA; Yule SM
Br J Haematol; 2000 Sep; 110(4):780-90. PubMed ID: 11054059
[No Abstract] [Full Text] [Related]
19. PEG-asparaginase.
Fu CH; Sakamoto KM
Expert Opin Pharmacother; 2007 Aug; 8(12):1977-84. PubMed ID: 17696798
[TBL] [Abstract][Full Text] [Related]
20. Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase.
Li Y; Zeng X; Wang S; Fan J; Wang Z; Song P; Mei X; Ju D
Tumour Biol; 2016 May; 37(5):6627-35. PubMed ID: 26643895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
